Richard Sposto

The genetic landscape of high-risk neuroblastoma

Trevor J. Pugh, Olena Morozova, Edward F. Attiyeh et al. · Nature Genetics · 2013 · 1.2K citations · Full text

Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

Roger J. Packer, Amar Gajjar, Gilbert Vézina et al. · Journal of Clinical Oncology · 2006 · 973 citations

The treatment of medulloblastoma

Audrey E. Evans, R. D. T. Jenkin, Richard Sposto et al. · Journal of neurosurgery · 1990 · 578 citations

Neuro-oncology, Surgical Oncology, Eligible Patients +15

Dexrazoxane-Associated Risk for Acute Myeloid Leukemia/Myelodysplastic Syndrome and Other Secondary Malignancies in Pediatric Hodgkin's Disease

Cameron K. Tebbi, Wendy B. London, Debra L. Friedman et al. · Journal of Clinical Oncology · 2007 · 480 citations · Full text

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

Catherine Patte, Anne Aupérin, Mary Gerrard et al. · Blood · 2006 · 427 citations · Full text